Health and Pharmaceutical Press Releases - Interfax Newswire

Health and Pharmaceutical Press Releases

2017-06-26 13:47 Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting

2017-06-26 10:52 Bionext Launches Biosight: an Online Platform That Will Revolutionize Pharmaceutical Research

2017-06-22 10:04 New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During Anesthesia

2017-06-21 17:08 New data reveal high rates of stroke history in asymptomatic atrial fibrillation patients

2017-06-20 15:07 Pacific Prime Joins Worldwide Broker Network as Newest Asia Pacific Region Member

2017-06-20 13:14 Hiroshima International University Releases "Cheatable Exam?"

2017-06-20 09:56 First-Ever World Kidney Cancer Q&A Day Highlights Growing Global Burden

2017-06-16 14:59 Merck Becomes Member of the Worldwide Innovative Network in Personalized Cancer Medicine - WIN Consortium (Paris)

2017-06-16 11:03 SERMO Announces Massive Global Expansion, Now Available in More Than 150 Countries

2017-06-15 10:00 Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA®

2017-06-15 09:58 Phase 2a Safety and Efficacy Data Support Further Development of Oral CC-220 in Patients with Lupus

2017-06-15 09:55 Pimodivir Alone or in Combination with Oseltamivir Demonstrated a Significant Reduction in Viral Load in Adults with Influenza A

2017-06-14 10:59 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery

2017-06-14 10:56 FX Creations’ Spacewalker 2nd Generation Backpack

2017-06-13 15:21 New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™

2017-06-12 15:10 Mannatech Finds Most Aloe Vera Products Are Missing This Key Feature That Makes the Difference to Your Health

2017-06-09 14:07 Updated Data from Phase 1 Trial of Oral IDHIFA® (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation

2017-06-08 10:06 Takeda and Seattle Genetics Announce Lancet Publication of Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma

2017-06-07 18:21 Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.

2017-06-06 16:00 Masimo Announces Limited Market Release of Rad-67™ rainbow® Pulse CO-Oximeter® with Next Generation SpHb®

Shanghai

Rm 703 Pan Pacific Tower, No. 1250 West Beijing Rd, Shanghai, China

+86 21 5239 8905

press@interfax.cn

Hong Kong

21-22/F, One Pacific Centre
414 Kwun Tong Road
Kowloon, Hong Kong

+852-2537 2262

press@interfax.cn

© 2008-2026 Interfax News Service Limited, all rights reserved.
Operated by Interfax News Service Limited, an independent company and an authorized distribution partner of Business Wire, Inc. Business Wire[®] is a [registered] trademark of Business Wire, Inc. Interfax News Service Limited is not an agent, partner or joint venturer of Business Wire, Inc.